Shanghai No.1 Pharmacy Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	368.92	436.42	400.03	504.93	262.28	509.43
Short-Term Investments	129.84	85.62	66.29	40	-	-
Trading Asset Securities	34.7	15.38	30.15	220.29	-	-
Cash & Short-Term Investments	533.45	537.41	496.47	765.22	262.28	509.43
Cash Growth	31.21%	8.25%	-35.12%	191.75%	-48.51%	7.54%
Accounts Receivable	177.61	190.15	247.57	238	133.56	130.82
Other Receivables	45.65	30.4	23.31	27.1	31.32	10.07
Receivables	223.26	220.55	270.88	265.1	164.87	140.89
Inventory	406.63	336.32	332.23	334.75	214.5	215.58
Prepaid Expenses	-	9.39	3.52	0.78	0.44	0.15
Other Current Assets	36.21	23.33	14.13	31.29	20.59	13.3
Total Current Assets	1,200	1,127	1,117	1,397	662.69	879.35
Property, Plant & Equipment	211.38	260.88	215.36	181.09	167.98	72.47
Long-Term Investments	328.86	342.74	322.45	252.47	184.14	180.14
Other Intangible Assets	37.17	38.93	41.67	43.83	46.33	48.19
Long-Term Deferred Tax Assets	36.04	24.35	26.39	35.99	12.07	7.19
Long-Term Deferred Charges	24.45	20.58	16.28	14.43	9.28	8.91
Other Long-Term Assets	193.23	165.58	123.78	114.15	251.97	200
Total Assets	2,031	1,980	1,863	2,039	1,334	1,396
Accounts Payable	439.85	384.14	398.59	363.69	314.8	291.97
Accrued Expenses	26.12	27.14	27.09	32.57	15.02	35.93
Short-Term Debt	99.61	95.58	101.05	320.28	-	180.11
Current Portion of Leases	57.41	63.98	58.34	49.05	38.94	-
Current Income Taxes Payable	-	0.9	10.27	37.33	5.93	3.6
Current Unearned Revenue	11.28	5.36	5.71	25.53	2.71	4.31
Other Current Liabilities	69.02	71.05	75.74	97.91	66.64	81.41
Total Current Liabilities	703.3	648.15	676.79	926.37	444.04	597.33
Long-Term Leases	78.67	115.56	107.24	88.33	63.08	-
Long-Term Unearned Revenue	11.62	11.97	12.44	11.3	11.68	12.4
Pension & Post-Retirement Benefits	2.35	2.5	2.42	-	-	-
Long-Term Deferred Tax Liabilities	64.47	57.48	55.83	54.34	37.34	36.46
Other Long-Term Liabilities	-	-	-	0.07	0.4	0.75
Total Liabilities	860.4	835.66	854.72	1,080	556.54	646.94
Common Stock	223.09	223.09	223.09	223.09	223.09	223.09
Additional Paid-In Capital	65.53	65.53	65.19	65.19	65.19	65.19
Retained Earnings	684.17	679.98	544.95	499.18	371.24	345.01
Comprehensive Income & Other	187.97	167.01	168.22	164.22	111.4	109.03
Total Common Equity	1,161	1,136	1,001	951.67	770.92	742.31
Minority Interest	9.54	8.79	7.01	7.01	7.01	7.01
Shareholders' Equity	1,170	1,144	1,008	958.68	777.92	749.32
Total Liabilities & Equity	2,031	1,980	1,863	2,039	1,334	1,396
Total Debt	235.69	275.12	266.63	457.67	102.03	180.11
Net Cash (Debt)	297.76	262.29	229.83	307.55	160.26	329.32
Net Cash Growth	92.88%	14.12%	-25.27%	91.91%	-51.34%	-30.48%
Net Cash Per Share	1.33	1.17	1.03	1.37	0.71	1.49
Filing Date Shares Outstanding	223.09	223.09	223.09	223.09	223.09	223.09
Total Common Shares Outstanding	223.09	223.09	223.09	223.09	223.09	223.09
Working Capital	496.25	478.85	440.44	470.77	218.65	282.02
Book Value Per Share	5.20	5.09	4.49	4.27	3.46	3.33
Tangible Book Value	1,124	1,097	959.77	907.85	724.58	694.12
Tangible Book Value Per Share	5.04	4.92	4.30	4.07	3.25	3.11
Buildings	-	105.19	89.34	94.76	94.76	95.56
Machinery	-	26.96	26.52	26	26.32	33.11
Construction In Progress	-	5.74	1.74	1.43	2.24	1.14

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.